Vor Biopharma Inc.
VOR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $865 |
| Gross Profit | $0 | $0 | $0 | -$865 |
| % Margin | – | – | – | – |
| R&D Expenses | $14,142 | $261,499 | $26,701 | $25,348 |
| G&A Expenses | $14,416 | $2,397 | $6,590 | $0 |
| SG&A Expenses | $14,416 | $2,397 | $6,590 | $5,098 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$451 | $10,388 | $0 | $0 |
| Operating Expenses | $28,107 | $274,284 | $33,291 | $30,446 |
| Operating Income | -$28,107 | -$274,284 | -$33,291 | -$31,311 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$784,577 | -$1,299,385 | $805 | $599 |
| Pre-Tax Income | -$812,684 | -$1,573,669 | -$32,486 | -$30,712 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$812,684 | -$1,573,669 | -$32,486 | -$30,712 |
| % Margin | – | – | – | – |
| EPS | -121.63 | -251.2 | -5.2 | -9 |
| % Growth | 51.6% | -4,730.8% | 42.2% | – |
| EPS Diluted | -121.63 | -251.2 | -5.2 | -9 |
| Weighted Avg Shares Out | 6,682 | 6,264 | 6,241 | 3,435 |
| Weighted Avg Shares Out Dil | 6,682 | 6,264 | 6,241 | 3,435 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,731 | $537 | $805 | $599 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2,037 | $825 | $865 |
| EBITDA | -$812,682 | -$241,513 | -$32,466 | -$29,847 |
| % Margin | – | – | – | – |